Novel Inhibitors of the Calcium-Activated K+ Channel KCa3.1 to Treat Non-Alcoholic Fatty Liver Disease and Liver Fibrosis
Biophysical Journal - United States
doi 10.1016/j.bpj.2018.11.1362
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 1, 2019
Authors
Publisher
Elsevier BV